GLOW Stack (70mg)

GLOW Stack (70mg)

$164.99
$164.99
SAVE Sold out

✔ Verified 99+% Purity

✔ Third-Party Approved & Tested

✔ Fast Australian Shipping

Research Use Only

This product is sold for research purposes only. It is not intended for human or animal consumption. By purchasing this product, you confirm that you are a qualified researcher or are purchasing for legitimate research purposes.

Bacteriostatic Water (20mg)
Add Bacteriostatic Water (20mg)
Required for reconstitution
$24.99
GLOW Stack (70mg)

GLOW Stack (70mg)

$164.99
$164.99
SAVE Sold out

Shipping Information

Orders are processed and dispatched within 24 hours of payment confirmation (Monday–Friday). Delivery typically arrives within 1–4 business days via Standard post, and 1-2 business days via Express post.

View full details

GLOW

Supplied as a lyophilized (freeze-dried) powder in a sealed sterile vial. Requires reconstitution with bacteriostatic water prior to use. Each vial contains a 70mg three-peptide blend at high purity, combining GHK-Cu, BPC-157, and TB-500 in a single formulation.

GLOW combines three peptides, each studied individually for skin repair and cellular renewal, in a single pre-blended vial. Each component addresses a distinct pathway: structural protein synthesis, inflammatory signalling, and angiogenic remodelling. GHK-Cu is the lead compound — an endogenous copper tripeptide whose concentration declines with age (from ~200 ng/mL at age 20 to ~80 ng/mL at 60) — studied for stimulating collagen and elastin synthesis, accelerating wound healing, and modulating gene expression linked to dermal repair. BPC-157 contributes anti-inflammatory and cytoprotective activity. TB-500 contributes angiogenic and cell-migration properties studied for structural remodelling.

Research Background

GLOW targets collagen and elastin synthesis, antioxidant defence, fibroblast activation, and extracellular-matrix remodelling. Research using these peptide components has investigated gene-expression modulation relevant to dermal regeneration, tissue repair, and cellular-senescence research. GHK-Cu's influence on gene expression is studied for shifting aged skin biology toward a younger repair state, while BPC-157 and TB-500 extend the blend's research utility to inflammatory signalling and vascular/migration mechanisms — allowing researchers to study structural, inflammatory, and angiogenic pathways within a single research protocol.

Key Research Areas
Collagen & elastin synthesis — GHK-Cu studied for stimulating structural protein production
Dermal gene expression — GHK-Cu's influence on gene expression is studied for shifting aged skin biology toward a younger repair state
Wound healing & skin repair — all three components studied for epidermal repair via complementary mechanisms
Inflammation modulation — BPC-157 studied for reducing inflammatory signalling in dermal tissue
Cellular turnover — studied for improved dermal cell turnover and microvascular supply
Studied Mechanisms
Copper ion cofactor activity supporting fibroblast and collagen synthesis (GHK-Cu)
Upregulation of antioxidant defence and DNA-repair genes (GHK-Cu)
Cytoprotective, anti-inflammatory signalling at the dermal tissue level (BPC-157)
Actin-sequestering, pro-migratory activity supporting angiogenesis (TB-500)
Combined/additive signalling across structural, inflammatory, and vascular pathways

Product Specifications

CategoryTissue Repair Research
CompositionGHK-Cu 56mg · BPC-157 7mg · TB-500 7mg
FormLyophilised Powder
ReconstitutionBacteriostatic water (recommended)
Purity≥99% (HPLC Verified)
StorageStore at -20°C, away from light and moisture
Research Use Only

This product is strictly intended for in vitro laboratory research purposes only. It is not approved for human or veterinary use, and is not intended for consumption, injection, or any therapeutic application.